Search
Check Out Our Sponsors
Latest topics
Sebum Transforming Growth Factor β1 Induced by Hair Products
3 posters
Page 1 of 1
Sebum Transforming Growth Factor β1 Induced by Hair Products
Sebum Transforming Growth Factor β1 Induced by Hair Products
Renée A. Beach, MD; Katalin A. Wilkinson, PhD; Freedom Gumedze, PhD; Nonhlanhla P. Khumalo, FCDerm, PhD
Arch Dermatol. 2012;148(6):764-766. doi:10.1001/archdermatol.2011.3533
Chemical hair processing is used by more than 60% of women with Afro-textured hair and is a suspected contributor to scarring alopecia. We recently reported changes in 6 proinflammatory cytokines on scalp sebum of 36 women.1 Baseline scalp interleukin (IL)-1α in all participants including those with natural hair was higher than expected (ie, 18 times IL-1ra levels), which may suggest a predisposition to scalp inflammation. However, there was no difference in levels of IL-1α when sebum from shampooed natural hair was compared with that treated with ammonium thioglycolate (permanent wave), sodium hydroxide (“lye”) and guanidine hydroxide (“no-lye”) relaxers. Changes in IL-1ra were significant on the vertex but not on the crown, which may suggest site-specific scalp predisposition to inflammation.
METHODS
In this study, samples from 36 participants (12 natural, 24 chemically treated) were tested for the presence of the profibrotic cytokine transforming growth factor (TGF) β1. The original study1 was conducted at Groote Schuur Hospital in 2010 and approved by the faculty ethics committee. Sebum was collected by applying Sebutape (CuDerm Corporation) to the scalp crown and vertex at visit 1 (before and after scalp shampoo), visit 2 (before and after chemical treatments), and on follow-up (visit 3). Details of chemical hair treatments and sample preparation for detection of cytokines have been described previously.1 Concentrations of TGF-β1 were determined using the Quantikine Human TGF-β1 Immunoassay (R&D Systems) according to the manufacturer's instructions.
Methods
Data analyses were performed using Stata software, version 12 (StataCorp LP).
Methods
Comparisons of interest were TGF-β1 levels with anatomic site after various chemical treatments and on follow-up. These comparisons were performed using Pearson χ2 and Fisher exact tests. Statistical significance was defined at the 5% alpha level (P = .05) for a 2-tailed hypothesis test.
Results
There was a significant difference (P = .02) in the age of participants with a positive TGF-β1 finding (Table), all detected in samples taken after shampoo or chemical treatment. Only 1 sample from natural hair tested positive for TGF-β1; this was after shampoo treatment. All samples that tested positive at visit 3 (when no shampoo or chemical treatment occurred) were previously chemically treated. Two participants had positive TGF-β1 test results (the first tested positive at both scalp sites on visit 1; the second had higher TGF-β1 levels detected on natural hair at visit 1 than on follow-up after treatment with a lye relaxer); a third participant had 3 detectable TGF-β1 levels on 2 visits.
Table. Summary Characteristics of Participants With Detectable Levels of TGF-β1a
http://archderm.jamanetwork.com/data/journals/derm/24221/m_drs110024t1.png
The number of participants with chemically treated hair was double that with natural hair. Overall, 16 samples (from 12 participants) yielded a positive TGF-β1 result; all except 1 of these were from chemically treated (94%) vs (6%) natural hair (Table). However, there was no statistically significant difference in detected TGF-β1 levels between samples from natural hair and chemical treatment groups (P = .23) nor within groups or scalp regions on different visits.
Comment
As a pleiotropic cytokine, TGF-β1 has roles in cell differentiation, proliferation, and inflammation. In scalps, TGF-β receptors have been reported to be strongly positive in proximal anagen hair follicles2 ; TGF-β1 is thought to induce regression of the hair follicle in catagen.2 Abundant levels of TGF-β1 have been found in the scalp dermis of patients with folliculitis decalvans and lichen planopilaris.3 These conditions are chronic and lead to scarring alopecia; TGF-β1 is postulated to mediate their fibrosis. Comparing data from biopsy specimens may not be appropriate because sebum was tested in this study, but changes in surface cytokines have been reported in scalp inflammation.4 Central centrifugal cicatricial alopecia (CCCA) predominantly affects women with Afro-textured hair. Although relaxer-induced acute CCCA-like scarring has been reported,5 the role of TGF-β1 is yet to be elucidated.
The detection of TGF-β1 after shampoo or chemical treatments in healthy subjects may suggest chemical interactions. The TGF-β isoforms are synthesized as latent precursors complexed with latent TGF-β binding protein (LTBP) or noncovalently bound to the latency-associated peptide (LAP). Extracellular dissociation from LTBP or LAP releases biologically active TGF-β. There are several conditions associated with this dissociation (activation), one of which is acidic pH.6 Most commercial shampoos are acidic (thought to induce less hair damage). However, TGF-β1 was not detected across all samples despite exposure of all to shampoo. Detectable levels of TGF-β1 at more than 1 visit may suggest a genetic predisposition and potential for scalp fibrosis, which may be influenced by hair grooming. Detection of TGF-β1 occurred predominantly in chemically altered hair but was inconsistent and lacked statistically significant difference in levels compared with findings in natural hair or between scalp sites. Large studies that correlate sebum cytokine levels and histologic characteristics may elucidate the association between hair chemical use and scarring alopecia.
AUTHOR INFORMATION
Correspondence: Dr Khumalo, Division of Dermatology, Ward G23, New Groote Schuur Hospital, Observatory 7925, Cape Town, South Africa (n.khumalo@uct.ac.za).
Renée A. Beach, MD; Katalin A. Wilkinson, PhD; Freedom Gumedze, PhD; Nonhlanhla P. Khumalo, FCDerm, PhD
Arch Dermatol. 2012;148(6):764-766. doi:10.1001/archdermatol.2011.3533
Chemical hair processing is used by more than 60% of women with Afro-textured hair and is a suspected contributor to scarring alopecia. We recently reported changes in 6 proinflammatory cytokines on scalp sebum of 36 women.1 Baseline scalp interleukin (IL)-1α in all participants including those with natural hair was higher than expected (ie, 18 times IL-1ra levels), which may suggest a predisposition to scalp inflammation. However, there was no difference in levels of IL-1α when sebum from shampooed natural hair was compared with that treated with ammonium thioglycolate (permanent wave), sodium hydroxide (“lye”) and guanidine hydroxide (“no-lye”) relaxers. Changes in IL-1ra were significant on the vertex but not on the crown, which may suggest site-specific scalp predisposition to inflammation.
METHODS
In this study, samples from 36 participants (12 natural, 24 chemically treated) were tested for the presence of the profibrotic cytokine transforming growth factor (TGF) β1. The original study1 was conducted at Groote Schuur Hospital in 2010 and approved by the faculty ethics committee. Sebum was collected by applying Sebutape (CuDerm Corporation) to the scalp crown and vertex at visit 1 (before and after scalp shampoo), visit 2 (before and after chemical treatments), and on follow-up (visit 3). Details of chemical hair treatments and sample preparation for detection of cytokines have been described previously.1 Concentrations of TGF-β1 were determined using the Quantikine Human TGF-β1 Immunoassay (R&D Systems) according to the manufacturer's instructions.
Methods
Data analyses were performed using Stata software, version 12 (StataCorp LP).
Methods
Comparisons of interest were TGF-β1 levels with anatomic site after various chemical treatments and on follow-up. These comparisons were performed using Pearson χ2 and Fisher exact tests. Statistical significance was defined at the 5% alpha level (P = .05) for a 2-tailed hypothesis test.
Results
There was a significant difference (P = .02) in the age of participants with a positive TGF-β1 finding (Table), all detected in samples taken after shampoo or chemical treatment. Only 1 sample from natural hair tested positive for TGF-β1; this was after shampoo treatment. All samples that tested positive at visit 3 (when no shampoo or chemical treatment occurred) were previously chemically treated. Two participants had positive TGF-β1 test results (the first tested positive at both scalp sites on visit 1; the second had higher TGF-β1 levels detected on natural hair at visit 1 than on follow-up after treatment with a lye relaxer); a third participant had 3 detectable TGF-β1 levels on 2 visits.
Table. Summary Characteristics of Participants With Detectable Levels of TGF-β1a
http://archderm.jamanetwork.com/data/journals/derm/24221/m_drs110024t1.png
The number of participants with chemically treated hair was double that with natural hair. Overall, 16 samples (from 12 participants) yielded a positive TGF-β1 result; all except 1 of these were from chemically treated (94%) vs (6%) natural hair (Table). However, there was no statistically significant difference in detected TGF-β1 levels between samples from natural hair and chemical treatment groups (P = .23) nor within groups or scalp regions on different visits.
Comment
As a pleiotropic cytokine, TGF-β1 has roles in cell differentiation, proliferation, and inflammation. In scalps, TGF-β receptors have been reported to be strongly positive in proximal anagen hair follicles2 ; TGF-β1 is thought to induce regression of the hair follicle in catagen.2 Abundant levels of TGF-β1 have been found in the scalp dermis of patients with folliculitis decalvans and lichen planopilaris.3 These conditions are chronic and lead to scarring alopecia; TGF-β1 is postulated to mediate their fibrosis. Comparing data from biopsy specimens may not be appropriate because sebum was tested in this study, but changes in surface cytokines have been reported in scalp inflammation.4 Central centrifugal cicatricial alopecia (CCCA) predominantly affects women with Afro-textured hair. Although relaxer-induced acute CCCA-like scarring has been reported,5 the role of TGF-β1 is yet to be elucidated.
The detection of TGF-β1 after shampoo or chemical treatments in healthy subjects may suggest chemical interactions. The TGF-β isoforms are synthesized as latent precursors complexed with latent TGF-β binding protein (LTBP) or noncovalently bound to the latency-associated peptide (LAP). Extracellular dissociation from LTBP or LAP releases biologically active TGF-β. There are several conditions associated with this dissociation (activation), one of which is acidic pH.6 Most commercial shampoos are acidic (thought to induce less hair damage). However, TGF-β1 was not detected across all samples despite exposure of all to shampoo. Detectable levels of TGF-β1 at more than 1 visit may suggest a genetic predisposition and potential for scalp fibrosis, which may be influenced by hair grooming. Detection of TGF-β1 occurred predominantly in chemically altered hair but was inconsistent and lacked statistically significant difference in levels compared with findings in natural hair or between scalp sites. Large studies that correlate sebum cytokine levels and histologic characteristics may elucidate the association between hair chemical use and scarring alopecia.
AUTHOR INFORMATION
Correspondence: Dr Khumalo, Division of Dermatology, Ward G23, New Groote Schuur Hospital, Observatory 7925, Cape Town, South Africa (n.khumalo@uct.ac.za).
_________________
My regimen
http://www.immortalhair.org/mpb-regimen
(Primary site under construction: )
Now available for consultation (hair and/or health)
http://www.immortalhair.org/health-consultation
Primary site under construction:
https://immortalhair.org/
Archived as of 2022 here:
https://web.archive.org/web/20220330061828/https://www.immortalhair.org/
Re: Sebum Transforming Growth Factor β1 Induced by Hair Products
I wonder if hairspray would induce this kind of reaction. I was using it for years when I started thinning pretty badly.
AS54- Posts : 2367
Join date : 2011-08-12
Age : 36
Location : MI
Re: Sebum Transforming Growth Factor β1 Induced by Hair Products
Does this suggest an accute reaction or an on going condition after using a hair relaxer? That is, does it change the condition of your scalp permanently after one use, or just as you have the product on your scalp? Because I have a buddy in a rock band who has been using hair relaxers for years and maintains a full head of hair. However, my hairdresser tried this on me once a long time ago and today I have less then a full head of hair.
Ace- Posts : 39
Join date : 2011-10-26
Similar topics
» Differential effects of caffeine on hair shaft elongation, matrix and outer root sheath keratinocyte proliferation, and transforming growth factor-β2/
» Induction of transforming growth factor-beta 1 by androgen is mediated by reactive oxygen species in hair follicle dermal papilla cells
» Vascular Endothelial Growth Factor Protects CD200-Rich and CD34-Positive Hair Follicle Stem Cells Against Androgen-Induced Apoptosis Through the Phosphoinositide 3-Kinase/Akt Pathway in Patients With Androgenic Alopecia.
» Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding
» Role for the epidermal growth factor receptor in chemotherapy-induced alopecia.
» Induction of transforming growth factor-beta 1 by androgen is mediated by reactive oxygen species in hair follicle dermal papilla cells
» Vascular Endothelial Growth Factor Protects CD200-Rich and CD34-Positive Hair Follicle Stem Cells Against Androgen-Induced Apoptosis Through the Phosphoinositide 3-Kinase/Akt Pathway in Patients With Androgenic Alopecia.
» Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding
» Role for the epidermal growth factor receptor in chemotherapy-induced alopecia.
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
Today at 2:36 pm by CausticSymmetry
» the NAD+ aging theory, a potential cure
Yesterday at 6:39 pm by Zaphod
» Summary of "Vitamin D: Evidence-Based Health Benefits and Recommendations for Population Guidelines
Yesterday at 8:51 am by CausticSymmetry
» John Lieurance and high dose melatonin
Yesterday at 6:28 am by mature_hairline_coper
» Natural phenylethanoid glycoside forsythoside A alleviates androgenetic alopecia by selectively inhibiting TRPV3 channels in mice
Wed Jan 22, 2025 8:49 am by CausticSymmetry
» The Hormonal Background of Hair Loss in Non-Scarring Alopecias
Wed Jan 22, 2025 8:39 am by CausticSymmetry
» Progress on the mechanism of natural products alleviating androgenetic alopecia
Wed Jan 22, 2025 8:36 am by CausticSymmetry
» An Overview of Commonly Used Natural Alternatives for the Treatment of Androgenetic Alopecia, with Special Emphasis on Rosemary Oil
Wed Jan 22, 2025 8:35 am by CausticSymmetry
» a little off topic (again)
Tue Jan 21, 2025 4:08 am by shaftless